[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356198-105":59,"doc-detail-356198-en":122},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":115,"head_meta":117,"extra_data":119,"updated_unix":121},105,"en","obesity-related-metabolic-dysfunction-and-triple-negative-breast-cancer-epidemiologic-signals-mechanistic-pathways-and-opportunities-for-prevention","Obesity-related Metabolic Dysfunction and Triple-negative Breast Cancer - Epidemiologic Signals, Mechanistic Pathways, and Opportunities for Prevention","","Reviewing epidemiologic, mechanistic, and translational evidence, the article examines how obesity-related metabolic dysfunction may contribute to triple-negative breast cancer (TNBC), beyond the well-established link between obesity and postmenopausal hormone receptor–positive disease. It synthesizes observational and Mendelian randomization findings, contrasting modest adiposity associations with heterogeneous causal-inference results. Mechanisms highlighted include adipose inflammation, adipokine imbalance, insulin/IGF-1 signaling, and immune remodeling that support biologic plausibility while not proving direct subtype conversion. It concludes with prevention-focused priorities.",{"@graph":69,"@context":114},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/obesity-related-metabolic-dysfunction-and-triple-negative-breast-cancer-epidemiologic-signals-mechanistic-pathways-and-opportunities-for-prevention/356198/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/obesity-related-metabolic-dysfunction-and-triple-negative-breast-cancer-epidemiologic-signals-mechanistic-pathways-and-opportunities-for-prevention/356198.png","ImageObject",300,407,{"name":92,"@type":93},"pixelkiddo","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108],{"name":109,"@type":110,"acceptedAnswer":111},"What prevention and research priorities does the review recommend?","Question",{"text":112,"@type":113},"The review calls for refined metabolic phenotyping, biomarker-driven risk stratification, validation in human-relevant models, and biomarker-enriched feasibility studies testing whether modifying metabolic dysfunction changes intermediate metabolic or tissue endpoints.","Answer","https://schema.org",{"og:url":83,"og:type":116,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":118,"canonical":83},"index,follow",{"doc_id":120,"site_id":62},356198,1790425812,{"code":4,"msg":5,"data":123},{"doc_id":120,"user_id":124,"nickname":92,"user_avatar":125,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":126,"file_id":127,"file_url":128,"file_type":129,"file_size":130,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":131,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":132,"faqs":133,"seo_title":134,"seo_description":67,"update_tm":135,"read_time":31,"preview_page_count":19,"preview_urls":136},962090883892,"https://ap-avatar.wpscdn.com/avatar/e00115db34f3e0f11b?x-image-process=image/resize,m_fixed,w_180,h_180&k=1790152879550218658","Current Obesity Reports (2026) 15:80  \n[https://doi.org/10.1007/s13679-026-00760-1](https://doi.org/10.1007/s13679-026-00760-1)  \nREVIEW  \nObesity-related Metabolic Dysfunction and Triple-negative Breast Cancer: Epidemiologic Signals, Mechanistic Pathways, and Opportunities for Prevention  \nNaser Elkum1 · Abdelilah Aboussekhra1  \nReceived: 2 July 2026 / Accepted: 6 September 2026 © The Author(s) 2026  \nAbstract  \nPurpose of Review Obesity is an established risk factor for postmenopausal hormone receptor–positive breast cancer, largely through estrogen-mediated pathways. Emerging evidence suggests that obesity-related metabolic dysfunction may also contribute to the risk and aggressive biology of receptor-negative breast cancer, particularly TNBC, among premenopausal women and populations undergoing rapid metabolic transition. This review evaluates epidemiologic, mechanistic, and translational evidence linking metabolic dysfunction to TNBC.  \nRecent Findings Observational studies and pooled analyses report modest but reproducible associations between adiposity and TNBC, stronger in some metabolically high-risk populations but heterogeneous across studies. BMI-based Mendelian randomization generally yields inverse associations with overall breast cancer, whereas bariatric-surgery studies suggest lower overall incidence without establishing TNBC-specific effects. These discordant causal-inference findings do not demonstrate that obesity directly causes TNBC. Mechanistic studies indicate that adipose inflammation, adipokine imbalance, insulin/IGF-1 signaling, and immune remodeling can promote inflammatory signaling, metabolic adaptation, and epithelial plasticity. These processes support biologic plausibility but do not demonstrate de novo conversion to a receptor-negative subtype in vivo.  \nSummary Current evidence supports a model in which obesity-related metabolic dysfunction may create a breast microenvironment favoring tumor-promoting inflammation and aggressive features associated with TNBC. Priorities include refined metabolic phenotyping, biomarker-driven risk stratification, validation in human-relevant models, and biomarker-enriched feasibility studies testing whether modifying metabolic dysfunction alters intermediate metabolic or tissue endpoints. An evidence-graded framework is needed to distinguish association, biologic plausibility, and causal inference.  \nKeywords Triple-negative breast cancer · Obesity · Metabolic dysfunction · Tumor microenvironment · Phenotypic plasticity · Stromal reprogramming  \n Naser Elkum [nelkum@kfshrc.edu.sa](nelkum@kfshrc.edu.sa)  \nAbdelilah Aboussekhra  \n[aboussekhra@kfshrc.edu.sa](aboussekhra@kfshrc.edu.sa)  \n1 Research Laboratories, Research and Innovation, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia  \nIntroduction  \nBreast cancer remains the most frequently diagnosed malignancy among women worldwide, accounting for more than 2.3 million new cases annually and representing a leading cause of cancer-related mortality [1] . Despite advances in early detection, molecular classification, and systemic therapy, substantial geographic and population-level disparities persist in both incidence and tumor subtype distribution [1] . In 2021, high BMI was associated with an estimated 356,740 cancer deaths and 8.89 million disability-adjusted life years globally, with substantial variation by sex, cancer type, and geographic region [2] . Figure 1A summarizes  \nFig. 1 Global burden of high BMI-attributable cancer and its relevance to aggressive breast cancer biology. (A) Geographic variation in the age-standardized proportion of cancer deaths attributable to high body mass index (BMI) in 2021, based on Global Burden of Disease Study 2021 data [2] . Darker shading indicates higher attributable fractions. Countries with the highest (>9%) and lowest (\u003C1%) burdens are annotated. (B) The estimated global numbers of cancer deaths attributable to high BMI in 2021 is presented","cbCaiaOUbCt7XcFy","https://ap.wps.com/l/cbCaiaOUbCt7XcFy","pdf",2367192,"English","# Abstract\n# Introduction\n## Global burden of high BMI and aggressive breast cancer relevance\n## Clinical definition and population patterns of TNBC","[{\"question\":\"What prevention and research priorities does the review recommend?\",\"answer\":\"The review calls for refined metabolic phenotyping, biomarker-driven risk stratification, validation in human-relevant models, and biomarker-enriched feasibility studies testing whether modifying metabolic dysfunction changes intermediate metabolic or tissue endpoints.\"}]","Obesity-related Metabolic Dysfunction and Triple-negative Breast Cancer - Epidemiologic Signals, Mechanistic Pathways, and Opportunities for Prevention | PDF",1790123985,[137,141,145,149],{"page_no":8,"url":138,"width":139,"height":140},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d1ae34775a10229ef87191ced521c838.webp",983,1305,{"page_no":14,"url":142,"width":143,"height":144},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d37ed9d48d812a74b73f53d993e79614.webp",982,1304,{"page_no":81,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/09bf14c4568a7492792a54877c6d162a.webp",981,1303,{"page_no":19,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3fc8f90d83a0a8f1cc5484e1d54628a2.webp",980,1301]